Inventor · disambiguated record
James D. Thompson
Also filed as: THOMPSON JAMES · THOMPSON JAMES D · THOMPSON JAMES DAVID
51 granted patents·30 pending applications·2,438 citations·filing 1978–2022
99Inventor score
Files withSIRNA THERAPEUTICS INC21RIBOZYME PHARM INC19HUGHES AIRCRAFT CO12HUGHES ELECTRONICS CORP4JT INT SA4
Top patents by PatentIndex Score
81 records- 0198US6673611B2Nucleic acid molecules with novel chemical compositions capable of modulating gene expressionSIRNA THERAPEUTICS INC·Filed 2001·Granted Jan 6, 2004·218 cites·17 claims
- 0298US5972704AHIV nef targeted ribozymesRIBOZYME PHARM INC·Filed 1997·Granted Oct 26, 1999·221 cites·22 claims
- 0398US4989011ADual mode phased array antenna systemHUGHES AIRCRAFT CO·Filed 1987·Granted Jan 29, 1991·191 cites·17 claims
- 0497US6146886ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1995·Granted Nov 14, 2000·200 cites·21 claims
- 0596US6852535B1Polymerase III-based expression of therapeutic RNASSIRNA THERAPEUTICS INC·Filed 2000·Granted Feb 8, 2005·54 cites·13 claims
- 0696US5530449APhased array antenna management system and calibration methodHUGHES AIRCRAFT CO·Filed 1994·Granted Jun 25, 1996·195 cites·6 claims
- 0795US5902880ARNA polymerase III-based expression of therapeutic RNAsRIBOZYME PHARM INC·Filed 1994·Granted May 11, 1999·308 cites·24 claims
- 0894US5012254APlural level beam-forming netowrkHUGHES AIRCRAFT CO·Filed 1989·Granted Apr 30, 1991·57 cites·10 claims
- 0991US6421528B1Satellite transmission system with adaptive transmission loss compensationHUGHES ELECTRONICS CORP·Filed 1999·Granted Jul 16, 2002·120 cites·14 claims
- 1090US4799065AReconfigurable beam antennaHUGHES AIRCRAFT CO·Filed 1986·Granted Jan 17, 1989·72 cites·6 claims
- 1187US6183959B1Method for target site selection and discoveryRIBOZYME PHARM INC·Filed 1998·Granted Feb 6, 2001·57 cites·48 claims
- 1286US7917519B2Categorized document basesSIZATOLA LLC·Filed 2006·Granted Mar 29, 2011·19 cites·34 claims
- 1385US6799014B2Satellite transmission system with adaptive transmission loss compensationBOEING CO·Filed 2002·Granted Sep 28, 2004·27 cites·13 claims
- 1485US5693535AHIV targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Dec 2, 1997·84 cites·100 claims
- 1584US5989906AMethod and reagent for inhibiting P-glycoprotein (mdr-1-gene)RIBOZYME PHARM INC·Filed 1994·Granted Nov 23, 1999·62 cites·6 claims
- 1684US4858229AFilter interconnection matrixHUGHES AIRCRAFT CO·Filed 1986·Granted Aug 15, 1989·47 cites·21 claims
- 1783US5750390AMethod and reagent for treatment of diseases caused by expression of the bcl-2 geneRIBOZYME PHARM INC·Filed 1992·Granted May 12, 1998·68 cites·13 claims
- 1881USD816025SCharger for an electric cigaretteJT INT SA·Filed 2016·Granted Apr 24, 2018·21 cites·1 claims
- 1981US4825172AEqual power amplifier system for active phase array antenna and method of arranging sameHUGHES AIRCRAFT CO·Filed 1987·Granted Apr 25, 1989·48 cites·33 claims
- 2079US6448009B1Method for target site selection and discoveryRIBOZYME PHARM INC·Filed 2000·Granted Sep 10, 2002·4 cites·39 claims
- 2173US5639655APML-RARA targeted ribozymesRIBOZYME PHARM INC·Filed 1994·Granted Jun 17, 1997·34 cites·9 claims
- 2273US4268561AMeans and method of manufacturing a high strength barTHOMPSON JAMES D·Filed 1979·Granted May 19, 1981·22 cites·9 claims
- 2372US8765931B2Double-stranded oligonucleotide compound for down-regulating the expression of CASP2 geneFEINSTEIN ELENA·Filed 2009·Granted Jul 1, 2014·1 cites·9 claims
- 2471US5966048ALow IMD amplification method and apparatusHUGHES ELECTRONICS CORP·Filed 1997·Granted Oct 12, 1999·74 cites·39 claims
- 2570US2006292691A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2670US2007004667A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2768US2006247429A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2868US2006287266A1RNA interference mediated ihibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2968US2006217336A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3065US9382542B2Double-stranded RNA compounds to CASP2 and uses thereofQUARK PHARMACEUTICALS INC·Filed 2013·Granted Jul 5, 2016·1 cites·10 claims
- 3165US5610052AEnzymatic RNA with activity to rasRIBOZYME PHARM INC·Filed 1992·Granted Mar 11, 1997·19 cites·12 claims
- 3265US5599704AErbB2/neu targeted ribozymesRIBOZYME PHARM INC·Filed 1995·Granted Feb 4, 1997·17 cites·14 claims
- 3365US2006281175A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3465US2006275903A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3565US2005176038A1Polymearase III-based expression of therapeutic RNAsSIRNA THERAPUTICS INC·Filed 2004·Application pending·0 cites
- 3663US4725797AMicrowave directional filter with quasi-elliptic responseHUGHES AIRCRAFT CO·Filed 1987·Granted Feb 16, 1988·17 cites·50 claims
- 3763US2006217337A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3863US2006247428A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 3963US2006217335A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4063US2006217334A1RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 4161US2005256068A1RNA interference mediated inhibition of stearoyl-CoA desaturase (SCD) gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 4259US7558541B2Amplifier gain and phase stabilizerBOEING CO·Filed 2004·Granted Jul 7, 2009·5 cites·19 claims
- 4359US5714383AMethod and reagent for treating chronic myelogenous leukemiaRIBOZYME PHARM INC·Filed 1994·Granted Feb 3, 1998·16 cites·26 claims
- 4458US2005176018A1Chemically modified double stranded nucleic acid moleculesSIRNA THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 4558US2003186923A1Method and reagent for inhibiting P-glycoprotein (mdr-1 gene)RIBOZYME PHARM INC·Filed 2003·Application pending·0 cites
- 4657US6159692AMethod and reagent for inhibiting human immunodeficiency virus replicationRIBOZYME PHARM INC·Filed 1999·Granted Dec 12, 2000·8 cites·27 claims
- 4757US2004033568A9Method and reagent for treatment of diseases caused by expression of the c-myc geneRIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 4856US5134417APlural frequency matrix multiplexerHUGHES AIRCRAFT CO·Filed 1990·Granted Jul 28, 1992·24 cites·3 claims
- 4956US2005164224A1RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)SIRNA THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 5055US8639181B2Lunar communications systemCAPLIN GLENN N·Filed 2008·Granted Jan 28, 2014·1 cites·28 claims
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when James D. Thompson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →